{"entity":{"type":"insider","cik":"0001581956","url":"/insider/0001581956","json_url":"/insider/0001581956.json","name":"Biller Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":90,"n_filings":55,"first":"2014-01-23","last":"2019-04-09","span_basis":"filed_date"},"name_variants":[{"name":"Biller Scott","source":"filing","n_filings":55,"first_seen":"2014-01-23","last_seen":"2019-04-09"}],"transactions":[{"id":8413231,"accession":"0001209191-19-024105","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-024105","line_url":"/filing/0001209191-19-024105","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":67.71183,"price_display":"67.71","price_state":"stated","total_value":203135.49,"total_display":"203,135.49","total_whole":"203,135","shares_owned_after":27110.0,"shares_owned_after_display":"27,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-05","filed_date":"2019-04-09","scope":"insider","n_lines":2},{"id":8692617,"accession":"0001209191-19-017738","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-017738","line_url":"/filing/0001209191-19-017738","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":67.67733333333334,"price_display":"67.68","price_state":"stated","total_value":203032.0,"total_display":"203,032.00","total_whole":"203,032","shares_owned_after":26711.0,"shares_owned_after_display":"26,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-05","filed_date":"2019-03-07","scope":"insider","n_lines":3},{"id":8451349,"accession":"0001209191-19-014933","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-014933","line_url":"/filing/0001209191-19-014933#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":585000.0,"total_display":"585,000.00","total_whole":"585,000","shares_owned_after":26511.0,"shares_owned_after_display":"26,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-27","filed_date":"2019-03-01","scope":"insider"},{"id":6662657,"accession":"0001209191-18-057556","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-057556","line_url":"/filing/0001209191-18-057556","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":69.69033333333333,"price_display":"69.69","price_state":"stated","total_value":209071.0,"total_display":"209,071.00","total_whole":"209,071","shares_owned_after":51732.0,"shares_owned_after_display":"51,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-05","filed_date":"2018-11-07","scope":"insider","n_lines":3},{"id":6142593,"accession":"0001209191-18-054513","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-054513","line_url":"/filing/0001209191-18-054513","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":69.79243333333334,"price_display":"69.79","price_state":"stated","total_value":209377.3,"total_display":"209,377.30","total_whole":"209,377","shares_owned_after":50953.0,"shares_owned_after_display":"50,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-05","filed_date":"2018-10-09","scope":"insider","n_lines":4},{"id":6001005,"accession":"0001209191-18-050043","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-050043","line_url":"/filing/0001209191-18-050043","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":83.07166666666667,"price_display":"83.07","price_state":"stated","total_value":249215.0,"total_display":"249,215.00","total_whole":"249,215","shares_owned_after":57296.0,"shares_owned_after_display":"57,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-07","scope":"insider","n_lines":3},{"id":6523325,"accession":"0001209191-18-045820","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-045820","line_url":"/filing/0001209191-18-045820","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":80.111,"price_display":"80.11","price_state":"stated","total_value":240333.0,"total_display":"240,333.00","total_whole":"240,333","shares_owned_after":57796.0,"shares_owned_after_display":"57,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-06","filed_date":"2018-08-08","scope":"insider","n_lines":3},{"id":6764700,"accession":"0001209191-18-041982","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-041982","line_url":"/filing/0001209191-18-041982","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":83.501,"price_display":"83.50","price_state":"stated","total_value":250503.0,"total_display":"250,503.00","total_whole":"250,503","shares_owned_after":57496.0,"shares_owned_after_display":"57,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-05","filed_date":"2018-07-09","scope":"insider","n_lines":2},{"id":6454969,"accession":"0001209191-18-036320","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-036320","line_url":"/filing/0001209191-18-036320","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":93.36691666666667,"price_display":"93.37","price_state":"stated","total_value":280100.75,"total_display":"280,100.75","total_whole":"280,101","shares_owned_after":58135.0,"shares_owned_after_display":"58,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-07","scope":"insider","n_lines":3},{"id":6100915,"accession":"0001209191-18-033646","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-033646","line_url":"/filing/0001209191-18-033646#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15177.0,"shares_display":"15,177","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":1365930.0,"total_display":"1,365,930.00","total_whole":"1,365,930","shares_owned_after":57196.0,"shares_owned_after_display":"57,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-23","filed_date":"2018-05-29","scope":"insider"},{"id":6016532,"accession":"0001209191-18-028538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-028538","line_url":"/filing/0001209191-18-028538#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":81.81,"price_display":"81.81","price_state":"stated","total_value":245430.0,"total_display":"245,430.00","total_whole":"245,430","shares_owned_after":57196.0,"shares_owned_after_display":"57,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-07","filed_date":"2018-05-08","scope":"insider"},{"id":6234743,"accession":"0001209191-18-024317","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-024317","line_url":"/filing/0001209191-18-024317","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":75.20233333333333,"price_display":"75.20","price_state":"stated","total_value":225607.0,"total_display":"225,607.00","total_whole":"225,607","shares_owned_after":58896.0,"shares_owned_after_display":"58,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-05","filed_date":"2018-04-09","scope":"insider","n_lines":4},{"id":6557180,"accession":"0001209191-18-017686","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-017686","line_url":"/filing/0001209191-18-017686","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":83.07633333333334,"price_display":"83.08","price_state":"stated","total_value":249229.0,"total_display":"249,229.00","total_whole":"249,229","shares_owned_after":53059.0,"shares_owned_after_display":"53,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-07","scope":"insider","n_lines":4},{"id":6196773,"accession":"0001209191-18-008108","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-008108","line_url":"/filing/0001209191-18-008108","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":76.04262333333334,"price_display":"76.04","price_state":"stated","total_value":228127.87,"total_display":"228,127.87","total_whole":"228,128","shares_owned_after":54160.0,"shares_owned_after_display":"54,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider","n_lines":4},{"id":6517315,"accession":"0001209191-18-003434","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-003434","line_url":"/filing/0001209191-18-003434#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":195000.0,"total_display":"195,000.00","total_whole":"195,000","shares_owned_after":53059.0,"shares_owned_after_display":"53,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-10","filed_date":"2018-01-12","scope":"insider"},{"id":4231250,"accession":"0001209191-17-063884","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-063884","line_url":"/filing/0001209191-17-063884","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2146.0,"shares_display":"2,146","price_per_share":60.791696178937556,"price_display":"60.79","price_state":"stated","total_value":130458.98,"total_display":"130,458.98","total_whole":"130,459","shares_owned_after":6964.0,"shares_owned_after_display":"6,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider","n_lines":3},{"id":4226323,"accession":"0001209191-17-059138","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-059138","line_url":"/filing/0001209191-17-059138","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2146.0,"shares_display":"2,146","price_per_share":62.68511649580615,"price_display":"62.69","price_state":"stated","total_value":134522.26,"total_display":"134,522.26","total_whole":"134,522","shares_owned_after":6264.0,"shares_owned_after_display":"6,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-03","scope":"insider","n_lines":4},{"id":5282489,"accession":"0001209191-17-056193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-056193","line_url":"/filing/0001209191-17-056193#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10470.0,"shares_display":"10,470","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":732900.0,"total_display":"732,900.00","total_whole":"732,900","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-04","filed_date":"2017-10-05","scope":"insider"},{"id":5320646,"accession":"0001209191-17-055856","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-055856","line_url":"/filing/0001209191-17-055856","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2146.0,"shares_display":"2,146","price_per_share":67.23,"price_display":"67.23","price_state":"stated","total_value":144275.58,"total_display":"144,275.58","total_whole":"144,276","shares_owned_after":6264.0,"shares_owned_after_display":"6,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider","n_lines":2},{"id":4447972,"accession":"0001209191-17-052622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-052622","line_url":"/filing/0001209191-17-052622#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581956","owner_name":"Biller Scott","owner_display_name":"Biller Scott","owner_url":"/insider/0001581956","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":975000.0,"total_display":"975,000.00","total_whole":"975,000","shares_owned_after":10470.0,"shares_owned_after_display":"10,470","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-11","filed_date":"2017-09-13","scope":"insider"}],"collapsed":true,"next_cursor":"2017-09-11|4447972","ledger_fault":false,"count":{"value":90,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":90,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":90},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS INC","url":"/issuer/0001439222","role":"Officer (Chief Scientific Officer)","n_filings":55,"first_seen":"2014-01-23","last_seen":"2019-04-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001581956","retrieved_at":"2026-08-23T22:38:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}